| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
2017 American Thoracic Society International Conference
|
van Dorn, Aaron
|
|
2017
|
5 |
7 |
p. 550-551
2 p.
|
artikel
|
| 2 |
A novel endpoint for exacerbations in asthma to accelerate clinical development: a post-hoc analysis of randomised controlled trials
|
Fuhlbrigge, Anne L
|
|
2017
|
5 |
7 |
p. 577-590
14 p.
|
artikel
|
| 3 |
Antacid therapy in idiopathic pulmonary fibrosis: more questions than answers?
|
Johannson, Kerri A
|
|
2017
|
5 |
7 |
p. 591-598
8 p.
|
artikel
|
| 4 |
Anti-interleukin 5 therapies in severe asthma
|
Passalacqua, Giovanni
|
|
2017
|
5 |
7 |
p. 537-538
2 p.
|
artikel
|
| 5 |
Australia's respiratory health in focus
|
Kirby, Tony
|
|
2017
|
5 |
7 |
p. 552-553
2 p.
|
artikel
|
| 6 |
Benralizumab for patients with mild to moderate, persistent asthma (BISE): a randomised, double-blind, placebo-controlled, phase 3 trial
|
Ferguson, Gary T
|
|
2017
|
5 |
7 |
p. 568-576
9 p.
|
artikel
|
| 7 |
Clearing the air: do facemasks protect health?
|
van Dorn, Aaron
|
|
2017
|
5 |
7 |
p. 555-556
2 p.
|
artikel
|
| 8 |
Clinical trial research in focus: improving drug development and trial design in pulmonary arterial hypertension
|
Lajoie, Annie Christine
|
|
2017
|
5 |
7 |
p. 544-546
3 p.
|
artikel
|
| 9 |
Controversies and conundrums in vocal cord dysfunction
|
Bardin, Philip G
|
|
2017
|
5 |
7 |
p. 546-548
3 p.
|
artikel
|
| 10 |
Corrections
|
|
|
2017
|
5 |
7 |
p. e26-
1 p.
|
artikel
|
| 11 |
Corrections
|
|
|
2017
|
5 |
7 |
p. e26-
1 p.
|
artikel
|
| 12 |
Cystic fibrosis transmembrane conductance-regulator modulators for children
|
Colombo, Carla
|
|
2017
|
5 |
7 |
p. 536-537
2 p.
|
artikel
|
| 13 |
Efficacy and safety of lumacaftor and ivacaftor in patients aged 6–11 years with cystic fibrosis homozygous for F508del-CFTR: a randomised, placebo-controlled phase 3 trial
|
Ratjen, Felix
|
|
2017
|
5 |
7 |
p. 557-567
11 p.
|
artikel
|
| 14 |
Fatigue in COPD: an important yet ignored symptom
|
Spruit, Martijn A
|
|
2017
|
5 |
7 |
p. 542-544
3 p.
|
artikel
|
| 15 |
Fighting for health: meet the doctor-activists
|
Burki, Talha Khan
|
|
2017
|
5 |
7 |
p. 554-555
2 p.
|
artikel
|
| 16 |
Improving precision in the prediction of asthma exacerbations
|
FitzGerald, J Mark
|
|
2017
|
5 |
7 |
p. 539-540
2 p.
|
artikel
|
| 17 |
Lung volume reduction for emphysema
|
Franzen, Daniel
|
|
2017
|
5 |
7 |
p. e23-
1 p.
|
artikel
|
| 18 |
Lung volume reduction for emphysema – Authors' reply
|
van Geffen, Wouter H
|
|
2017
|
5 |
7 |
p. e24-
1 p.
|
artikel
|
| 19 |
Maximal bronchodilation: a therapeutic target in COPD?
|
Agustí, Alvar
|
|
2017
|
5 |
7 |
p. 540-542
3 p.
|
artikel
|
| 20 |
Maximising the data potential in COPD research
|
The Lancet Respiratory Medicine,
|
|
2017
|
5 |
7 |
p. 535-
1 p.
|
artikel
|
| 21 |
The TRINITY study: Twitter discussion from a respirology journal club
|
Brijbassi, Melissa
|
|
2017
|
5 |
7 |
p. e25-
1 p.
|
artikel
|
| 22 |
The TRINITY study: Twitter discussion from a respirology journal club – Authors' reply
|
Vestbo, Jørgen
|
|
2017
|
5 |
7 |
p. e26-
1 p.
|
artikel
|
| 23 |
Vocal cord dysfunction or inducible laryngeal obstruction: whatever it is, it exists
|
Herth, Felix J F
|
|
2017
|
5 |
7 |
p. 548-549
2 p.
|
artikel
|
Tijdschrift beschrijving